Fausto Castagnetti

Fausto Castagnetti

UNVERIFIED PROFILE

Are you Fausto Castagnetti?   Register this Author

Register author
Fausto Castagnetti

Fausto Castagnetti

Publications by authors named "Fausto Castagnetti"

Are you Fausto Castagnetti?   Register this Author

100Publications

2936Reads

47Profile Views

The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview.

Leukemia 2019 05 23;33(5):1173-1183. Epub 2019 Jan 23.

Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie (IBE), Ludwig-Maximilians-Universität München, Munich, Germany.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41375-018-0341-4
Publisher Site
http://dx.doi.org/10.1038/s41375-018-0341-4DOI Listing
May 2019

Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia.

Mycoses 2018 Jan 22;61(1):53-60. Epub 2017 Sep 22.

Institute of Hematology "Lorenzo e Ariosto Seràgnoli", Department of Specialistic Diagnostic and Experimental Medicine (DIMES), Sant'Orsola-Malpighi Hospital Teaching Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/myc.12697
Publisher Site
http://dx.doi.org/10.1111/myc.12697DOI Listing
January 2018

FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage.

J Cell Biochem 2017 11 30;118(11):3968-3975. Epub 2017 May 30.

Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Institute of Hematology L. and A. Seràgnoli-University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcb.26052DOI Listing
November 2017

Chibby 1: a new component of β-catenin-signaling in chronic myeloid leukemia.

Oncotarget 2017 Oct 22;8(50):88244-88250. Epub 2017 Sep 22.

Department of Experimental Diagnostic and Specialty Medicine, DIMES-Institute of Hematology "L. and A. Seràgnoli", University of Bologna Medical School, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.21166DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675707PMC
October 2017

Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?

Nat Rev Clin Oncol 2017 03 18;14(3):141-154. Epub 2016 Oct 18.

Institute of Haematology and Medical Oncology Lorenzo ed Ariosto Seràgnoli, Department of Experimental, Diagnostic and Specialty Medicine, Bologna University School of Medicine, S.Orsola-Malpighi University Hospital, Via Massarenti 9, 40138 Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2016.139DOI Listing
March 2017

DNA methyltransferase 1 drives transcriptional down-modulation of β catenin antagonist Chibby1 associated with the BCR-ABL1 gene of chronic myeloid leukemia.

J Cell Biochem 2015 Apr;116(4):589-97

Dipartimento di Medicina Specialistica, Diagnostica a Sperimentale-DIMES, Istituto di Ematologia "L. e A. Seràgnoli" - University of Bologna - Medical School, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcb.25010DOI Listing
April 2015

A review of the European LeukemiaNet recommendations for the management of CML.

Ann Hematol 2015 Apr 27;94 Suppl 2:S141-7. Epub 2015 Mar 27.

Department of Hematology and Oncology "L. and A. Seràgnoli", University of Bologna, S. Orsola-Malpighi University Hospital, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-015-2322-2DOI Listing
April 2015

BCR-ABL1-associated reduction of beta catenin antagonist Chibby1 in chronic myeloid leukemia.

PLoS One 2013 10;8(12):e81425. Epub 2013 Dec 10.

Istituto di Ematologia "Lorenzo e Ariosto Seràgnoli", Dipartimento di Medicina Specialistica Diagnostica e Sperimentale - DIMES, University of Bologna - Medical School, Bologna, Italy.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0081425PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858264PMC
March 2015

A calpain-cleaved fragment of β-catenin promotes BCRABL1+ cell survival evoked by autophagy induction in response to imatinib.

Cell Signal 2014 Aug 18;26(8):1690-7. Epub 2014 Apr 18.

Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale DIMES, Istituto di Ematologia "L. e A. Seràgnoli," University of Bologna, Medical School, via Massarenti, 940138 Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellsig.2014.04.010DOI Listing
August 2014

Definition and treatment of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia.

Expert Rev Hematol 2014 Jun 25;7(3):397-406. Epub 2014 Mar 25.

Department of Hematology and Oncology "L. and A. Seràgnoli", Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2014.900432DOI Listing
June 2014

First-line treatment of newly diagnosed elderly patients with chronic myeloid leukemia: current and emerging strategies.

Drugs 2014 Apr;74(6):627-43

Institute of Hematology "L. e A. Seragnòli", Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, S.Orsola-Malpighi Hospital, Via Massarenti 9, 40138, Bologna, Italy,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40265-014-0207-7DOI Listing
April 2014

Treatment recommendations for chronic myeloid leukemia.

Mediterr J Hematol Infect Dis 2014 Jan 2;6(1):e2014005. Epub 2014 Jan 2.

Institute of Hematology "L. and A. Seràgnoli", Department of Specialty, Diagnostic and Experimental Medicine, University of Bologna, S.Orsola-Malpighi University Hospital, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4084/MJHID.2014.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894838PMC
January 2014

Impact of comorbidities on the treatment of chronic myeloid leukemia with tyrosine-kinase inhibitors.

Expert Rev Hematol 2013 Oct 2;6(5):563-74. Epub 2013 Oct 2.

Department of Experimental, Diagnostic and Specialty Medicine, S.Orsola-Malpighi Hospital, University of Bologna, Institute of Hematology "L. e A. Seragnòli", Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17474086.2013.837279DOI Listing
October 2013

Chibby drives β catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells.

Cell Signal 2013 Sep 24;25(9):1820-7. Epub 2013 May 24.

Department of Experimental Diagnostic and Specialty Medicine - DIMES - Institute of Hematology L and A Seràgnoli, University of Bologna-Medical School, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellsig.2013.05.019DOI Listing
September 2013

Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phase.

Crit Rev Oncol Hematol 2012 May 11;82(2):159-70. Epub 2011 May 11.

Department of Hematology and Oncology L. and A. Seràgnoli, University of Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2011.04.002DOI Listing
May 2012

Physician's guide to the clinical management of adverse events on nilotinib therapy for the treatment of CML.

Cancer Treat Rev 2012 May 12;38(3):241-8. Epub 2011 Aug 12.

Department of Hematology and Oncology, L. and A. Seràgnoli, St. Orsola University Hospital, University of Bologna, 9-40138 Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2011.07.004DOI Listing
May 2012

Imatinib in chronic myeloid leukemia elderly patients.

Aging (Albany NY) 2011 Dec;3(12):1125-6

Department of Hematology and Clinical Oncology "Seràgnoli", S.Orsola-Malpighi Hospital, University of Bologna, Italy.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273892PMC
http://dx.doi.org/10.18632/aging.100420DOI Listing
December 2011

Explaining the in vitro and in vivo differences in leukemia therapy.

Cell Cycle 2011 May 15;10(10):1540-4. Epub 2011 May 15.

Université Libre de Bruxelles, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.10.10.15518DOI Listing
May 2011

Dasatinib and nilotinib in imatinib-resistant Philadelphia-positive chronic myelogenous leukemia: a 'head-to-head comparison'.

Leuk Lymphoma 2010 Apr;51(4):583-91

Department of Hematology and Oncology L. e A. Seràgnoli, S. Orsola-Malpighi University Hospital, 9-40138 Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428191003637282DOI Listing
April 2010

Pancreatic enzyme elevation in chronic myeloid leukemia patients treated with nilotinib after imatinib failure.

Haematologica 2009 Dec 16;94(12):1758-61. Epub 2009 Jul 16.

Department of Hematology and Medical Oncology L. and A. Seràgnoli, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2009.010496DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791949PMC
December 2009

Response definitions and European Leukemianet Management recommendations.

Best Pract Res Clin Haematol 2009 Sep;22(3):331-41

Department of Hematology-Oncology L. and A. Seràgnoli, S.Orsola-Malpighi University Hospital, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2009.10.001DOI Listing
September 2009